News
Boosting peptide design Finding the holy grail of re-engineering peptide design -- for better antibiotics and beyond Date: May 10, 2021 Source: Monash University Summary: Peptides play a vital ...
3d
GlobalData on MSNAtombeat and BioDuro link for peptide drug discovery platformAtombeat and BioDuro have announced a strategic partnership to launch an AI-powered platform aimed at accelerating peptide ...
Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology ...
AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced compelling in vitro results demonstrating that its artificial ...
Recent advances in peptide design have transformed the approach to modulating protein-protein interactions (PPIs), a field that underpins much of cellular signalling and disease pathology. By ...
Integrated design of peptide-based nanomedicine in cancer treatment. The process of nanomedicine development involves simulation-guided peptide drug design, evaluation against both 2D and 3D cell ...
Cell-penetrating peptides are a class of short peptides with a length of 5~30 amino acids, which can carry peptides, nucleic acids, small molecules of drugs, and virus particles through cell membranes ...
In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically "undruggable" protein, in just two months ...
News Release 24-Jan-2025 Scientists design peptides to enhance drug efficacy The work could lead to more effective drug therapies for a variety of diseases, including cancer. Peer-Reviewed Publication ...
BEIJING, Jan. 9, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results